Pfizer is taking a novel tactic in its approach to the Russian war against Ukraine as CEO Albert Bourla told staffers on Wednesday that the company is putting its first ...

Small RSV con­tender eyes 'first-to-mar­ket' op­por­tu­ni­ty with $225M Asia deal ...

The federal government has only sent four shipments of Merck's Covid-19 antiviral molnupiravir (about 400,000 courses in each shipment) nationwide, and already HHS is reporting that some ...

B Capital, an investment firm co-founded by Eduardo Saverin of Facebook fame, has closed its inaugural healthcare fund. Add that to its capital growth fund, and B Capital says it ...

Mod­er­na preps for a pri­vate, more ex­pen­sive Covid-19 vac­cine mar­ket as Biden ad­min frets over un­in­ten­tion­al shift ...

Confirmed monkeypox cases in the US have now surpassed 300, and as a result, the Department of Health and Human Services is making hundreds of thousands of Bavarian Nordic’s vaccine ...

The FDA recently added a new warning and precaution to the label of Horizon's blockbuster monoclonal antibody Tepezza (teprotumumab-trbw), which is used as a treatment for thyroid eye disease, to ...

After its Covid-19 vaccine candidate petered out, CureVac earlier this month filed suit against BioNTech in German court, stating that CureVac should be compensated for the alleged infringement of ...

Just weeks after the FDA announced its hold on foreign inspections will continue into February, the feds' accountability office is calling upon the regulatory agency to make changes to improve ...

Below are notable updates from the American Academy of Dermatology’s annual meeting over the weekend: Sanofi amends trial protocol Sanofi has big plans for amlitelimab, the monoclonal antibody ...

Pfizer and Astellas are gunning to add a fourth indication to their cancer drug Xtandi with Phase III trial results released today. The study, looking at ...

LinusBio, a Mount Sinai spinoff starting out focused on neurological disorders like autism, announced Thursday it raised $16 million in Series A funding. Proceeds will go toward building its ...